Society of Urologic Oncology Clinical Trials Consortium

Analysis

Society of Urologic Oncology Clinical Trials Consortium is a registered charity in United States, based in Schaumburg, IL. It received its IRS tax-exemption ruling in March 2010, 16 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending April 2023, Society of Urologic Oncology Clinical Trials Consortium reported income of $332k and spending of $238k, leaving 28% of income unspent that year. Across the 4 years on record, from April 2020 to April 2023, income grew from $214k to $332k (+55%), an average of +16% a year. The sharpest change came in the year to April 2022, when income rose by 185%. Over the whole period it spent 53% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Society of Urologic Oncology Clinical Trials Consortium sits at the 49th percentile: it is larger than about 49% of them. Against every charity in United States with reported income it ranks in the 64th percentile, and in the 64th percentile within IL. Charities of a similar size with the same main cause include Hope in View Inc ($332k), Voices of Hope Inc ($332k) and Point of Return Inc ($332k).

On its Form 990 for the period ending April 2023, revenue came from program service revenue 100% of the total. At year end it held assets of $1.1m against liabilities of $33k, net assets of $1.1m.